(Q62811656)

English

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Randomised, Double-blinded, Multiple-dose, Dose-escalation Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Subjects With Overweight or Obesity (English)

0 references

0 references

0 references

United States of America

0 references

start time

13 March 2018

0 references

end time

11 April 2019

0 references

number of participants

60

0 references

clinical trial phase

phase I clinical trial

0 references

research site

Novo Nordisk

0 references

research subject recruitment status

completed

0 references

minimum age

22 year

0 references

maximum age

55 year

0 references

uses

partial thromboplastin time

1 reference

retrieved

12 December 2021

reference URL

https://clinicaltrials.gov/ct2/results?cond=&term=%22partial+thromboplastin+time%22

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03479892

0 references

(Q62811656)

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)